Prostate Cancer

>

Latest News

“The machine learning algorithms based on pure clinical data aren’t any better, [but] that’s where prostate cancer algorithms are starting to shine,” said James B. Yu, MD, MHS, FASTRO.
AI Use May Improve Treatment Outcomes in Prostate Cancer

July 17th 2024

“The machine learning algorithms based on pure clinical data aren’t any better, [but] that’s where prostate cancer algorithms are starting to shine,” said James B. Yu, MD, MHS, FASTRO.

Developers plan to submit data from the ARANOTE trial to global regulatory health authorities to expand indications for darolutamide in metastatic HSPC.
Darolutamide Combo Improves Radiological PFS in Metastatic HSPC

July 17th 2024

In addition to tissue biopsy, a liquid biopsy test can be used to better identify patients who may benefit from niraparib and abiraterone acetate.
FDA Approves FoundationOne Liquid CDx for Niraparib Combo in BRCA+ mCRPC

July 1st 2024

In a phase 1 trial, City of Hope’s CAR T-cell therapy showed minimal adverse effects and promising therapeutic activity for advanced prostate cancer.
CAR T-Cell Therapy Demonstrates Promising Results for mCRPC

June 27th 2024

Compared with cognitively-defined and hemigland contours, AI-assisted cancer contours delivered a greater balanced accuracy rate.
AI-Assisted Contours Exhibit High Accuracy in Evaluating Prostate Cancer

June 20th 2024

More News